Shaping the Future of PBM: Global Guidance & Innovation
Friday 25 April
CEST: 18:30 – 19:30
Local time: 18:30
Join NATA and PBM societies from around the world for 24 hours of non-stop PBM, anaemia, transfusion, coagulation education in your region.
Programme and registration opening soon.
Shaping the Future of PBM: Global Guidance & Innovation
Friday 25 April
CEST: 18:30 – 19:30
Local time: 18:30
O manejo da Anemia no contexto do PBM no Brasil, desafios e oportunidades
Friday 25 April
CEST: 19:45 – 20:45
ISTH – International Society on Thrombosis and Hemostasis / World Thrombosis Day
Friday 25 April
CEST: 21:00 – 22:00
Smart PBM: Effective Patient Blood Management in Anemia and Intraoperative Recovery
Friday 25 April
CEST: 22:15 – 23:15
What are your TOP 5 Professional Challenges in Achieving PBM?
Friday 25 April
CEST: 22:15 – 23:15
Local time: 16:15
SIAPBM e Iberoamérica: Reflexiones regionales e historias exitosas
Friday 25 April
CEST: 23:30- 00:30
Algorithm for the Management of Serious OAC-related Bleeding: Canadian Context
Saturday 26 April
CEST: 00:45 – 01:45
Patient Blood Management in New Zealand
Saturday 26 April
CEST: 02:00 – 03:00
Advances in Patient Blood Management in Korea
Saturday 26 April
CEST: 03:15 – 04:15
Chinese Society of Cardiothoracic and Vascular Anesthesiolgy (CSCTVA)
Saturday 26 April
CET: 04:30 – 05:30
Multifaceted approach in PBM
Saturday 26 April
CET: 05:45 – 06:45
Paediatric Patient Blood Management for major surgeries
Saturday 26 April
CET: 07:00 – 08:00
Future of PBM & Blood health: Strides in Asia-Pacific
Saturday 26 April
CET: 08:15 – 09:15
Blood Management in Lebanon: Adapting and Innovating in Crisis Conditions
Saturday 26 April
CET: 09:30 – 10:30
PBM in Sub-Saharan Africa
Saturday 26 April
CET: 12:00 – 13:00
Local: 14:00 – 15:00
Anémie – Regards Croisés
Saturday 26 April
CET: 13:15 – 14:15
Ask the WFSA P-PBM Champions
Saturday 26 April
CET: 14:30 – 15:30
NATA25 Highlights: Key Moments & Voices
Saturday 26 April
CET: 15:45 – 16:45
Lorem ipsum odor amet, consectetuer adipiscing elit. Dictum ipsum per platea taciti libero sapien ullamcorper et purus. Lectus inceptos ligula nibh quisque luctus maximus. Nascetur primis diam massa ut elit
Despite studies supporting a restrictive red cell transfusion strategy in many medical situations, a more liberal strategy is still widely used in patients who need extracorporeal membrane oxygenation (ECMO), Alexander
Anticoagulation treatment has been revolutionised in the past few decades with the development of drugs that increasingly target individual components of the coagulation cascade. Yet the quest to find improved
Tranexamic acid (TXA) is safe to use to prevent bleeding in patients at the time of surgery, even in those at risk of thrombosis, according to Patrick Meybohm (University Hospital
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther healthcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.